Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL0600061	重组人血管内皮生长因子受体-抗体融合蛋白注射液（静脉给药）	Injection	Biological Products(1)	New Drug Application	2006-12-14	成都康弘生物科技有限公司	Chengdu Kanghong Biotechnology Co Ltd	Certificate Issued	2009-02-11	view
CXSB1400009	重组人血管内皮生长因子受体-抗体融合蛋白注射液(静脉给药)	Injection	Biological Products	Supplementary Application	2014-08-28	成都康弘生物科技有限公司	Chengdu Kanghong Biotechnology Co Ltd	Certificate Issued	2015-08-11	view
CXSB1400010	重组人血管内皮生长因子受体-抗体融合蛋白注射液(静脉给药)	Injection	Biological Products	Supplementary Application	2014-08-28	成都康弘生物科技有限公司	Chengdu Kanghong Biotechnology Co Ltd	Certificate Issued	2015-08-11	view
CXSB1800003	重组人血管内皮生长因子受体-抗体融合蛋白注射液(静脉给药)	Injection	Biological Products	Supplementary Application	2018-03-06	成都康弘生物科技有限公司	Chengdu Kanghong Biotechnology Co Ltd	Certificate Issued	2018-05-24	view